Drugs / Inactivated Influenza A/H5N1 Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00280033 | Feb → Nov 2006 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Influenza A/H5N1 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00280033 ↗ |
| Modality | Vaccine | “influenza A/H5N1 virus vaccine” NCT00280033 ↗ |
| Route | Intramuscular | “administered by intramuscular (IM) injection” NCT00280033 ↗ |